A clinical trial and molecular study of photoadaptation in vitiligo.
BACKGROUND
Photoadaptation to ultraviolet (UV) B phototherapy is due to both pigmentary and nonpigmentary influences.


OBJECTIVE
To measure photoadaptation in vitiliginous skin and to compare it with normal pigmented skin.


METHODS
Seventeen patients with Fitzpatrick skin phototypes III-VI with vitiligo received six to nine UVB treatments, two to three times weekly. Minimal erythema dose (MED) testing was done at baseline and after all treatments; the percentage change in MED was analysed as a measure of photoadaptation. The percentage decrease in cyclobutane pyrimidine dimers (CPDs) over 24 h after a single exposure of 1 MED was analysed on vitiliginous and normal skin.


RESULTS
The mean +/- SD percentage change in MED from before to after treatments was: treated vitiliginous skin 28.5 +/- 39.9% (P = 0.015), treated normal skin 35.9 +/- 49.9% (P = 0.015), untreated vitiliginous skin 11.9 +/- 22.6% (P =0.070), untreated normal skin 25.1 +/- 41.3% (P = 0.041). Of these patients, two-thirds had a positive percentage change in MED (photoadaptation). The mean amount of CPDs induced per megabase of DNA immediately after exposure was significantly higher in vitiliginous skin. The mean +/- SD percentage decrease in CPDs (rate of repair) in 24 h was 35.7 +/- 26.8% in vitiliginous skin (P = 0.027) and 46.2 +/- 19.5% in normally pigmented skin (P = 0.001); no difference was noted in the repair in vitiliginous skin compared with normal skin (P = 0.4).


CONCLUSIONS
Photoadaptation in vitiliginous and normal skin was observed in two-thirds of patients. Vitiliginous skin had significantly more CPDs following UVB exposure; the rate of repair of UVB-induced DNA damage was equivalent to that in normal skin.
Hexsel
C L
CL
Multicultural Dermatology Center, Department of Dermatology, Henry Ford Hospital, Detroit, MI 48202, USA.
Mahmoud
B H
BH
Mitchell
D
D
Rivard
J
J
Owen
M
M
Strickland
F M
FM
Lim
H W
HW
Hamzavi
I
I
D000222:Adaptation, Physiological / Q000235:genetics / Q000528:radiation effects*; D000328:Adult; D000368:Aged; D004249:DNA Damage; D004260:DNA Repair; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011836:Radiation Tolerance / Q000235:genetics; D011879:Radiotherapy Dosage; D012867:Skin / Q000528:radiation effects; D012880:Skin Pigmentation; D014467:Ultraviolet Therapy / Q000379:methods*; D014820:Vitiligo / Q000235:genetics / Q000503:physiopathology / Q000532:radiotherapy*